Regulatory Affairs

At Global RQC Med Dev Consulting Solutions, we specialize in regulatory affairs for the medical device industry, offering comprehensive solutions to ensure your products meet the stringent regulatory standards required by health authorities worldwide. If you’re looking to navigate the FDA approval process, expand into new markets, or maintain compliance with global regulations, our team is here to provide you with the expertise you need to streamline your regulatory submissions and reduce time-to-market.

In the competitive and highly regulated medical device industry, ensuring that your products comply with international regulations is paramount. We provide end-to-end solutions that cover regulatory submissions, new product development pathways, global registrations, and more. With a deep understanding of both regulatory compliance and the complexities of global markets, we help you get your products to market efficiently and safely, ensuring you meet all necessary legal requirements.

Regulatory Submissions

New Product Development

Registrations & Device Listings

Global Regulatory

Independent Reviews

Combination Product

Regulatory Submissions (510(k), MDL, Technical Documentation)

The process of regulatory submission is one of the most critical aspects of bringing a medical device to market. Our team at Global RQC assists with all types of regulatory submissions, ensuring that your product is in full compliance with regulatory requirements for FDA 510(k) clearance, Medical Device Licensing (MDL), and other documentation needs.

510(k) Submissions: If your device is a medical device subject to FDA regulations, we can help you navigate the 510(k) premarket notification process. This process ensures that your device is substantially equivalent to a legally marketed device, providing a pathway for quicker market access. Our team ensures that all necessary data, testing results, and device descriptions are included in your submission to meet FDA requirements.
Medical Device Licensing (MDL): We also help you with MDL submissions for devices intended for markets outside the United States. Depending on the country, MDL procedures can vary. Our team is experienced in preparing technical documentation required for regulatory agencies in the EU, Canada, Japan, and other regions, ensuring that your product complies with local regulations.
Technical Documentation: Developing comprehensive technical documentation is essential to demonstrate compliance with regulatory requirements. We support you in creating detailed design dossiers, including design history files, risk management files, and clinical evaluation reports to ensure your device meets all regulatory standards.

By offering comprehensive submission services, we enable you to navigate complex regulatory landscapes, ensuring that your products meet market standards and reach your target audience faster.

New Product Development Pathways

Launching a new medical device requires careful planning and strategy to ensure regulatory approval and market success. At Global RQC, we offer strategic guidance on new product development pathways, from early-stage concept to commercialization.

Feasibility Assessment: Our consultants assess the feasibility of your device development project, including regulatory strategy, risk management, and market entry. We help you evaluate potential roadblocks early on, identify compliance challenges, and develop strategies for navigating these obstacles.
Design and Development: We guide you through the design and development phases, ensuring that your device meets both regulatory requirements and market needs. This includes creating design specifications, selecting suitable materials, and conducting preclinical and clinical trials. Our consultants provide the expertise needed to streamline the development process and optimize your timeline.
Regulatory Strategy: We assist in formulating an effective regulatory strategy based on the product’s risk classification, intended use, and geographic markets. Whether you need to meet FDA requirements or adhere to CE marking standards for the European market, we help you determine the optimal regulatory pathway and plan your submission process accordingly.

Our new product development pathway services provide a roadmap that aligns your product with both market expectations and regulatory standards, ensuring a smooth and successful product launch.

Registrations & Device Listings

Navigating registrations and device listings is essential for ensuring that your product is recognized and approved by the relevant regulatory authorities. At Global RQC, we assist you with registering your product with regulatory bodies and listing it in their databases, which is critical for legal marketing and sales.

FDA Device Registration: In the U.S., every medical device must be registered with the FDA before being marketed. We guide you through the FDA registration process, ensuring that your product meets all necessary requirements and is properly listed in the FDA’s Medical Device Listing Database.
Global Device Listings: Our team also helps with registrations in international markets. Whether it’s the European Union, Japan, or Canada, we ensure that your device is properly registered with the relevant health authorities. This involves providing the necessary documentation and testing results to meet each country’s requirements, allowing you to market your device globally.

Efficient and accurate device registration and listing are essential for gaining market access and avoiding costly delays. Our team ensures that your products meet all necessary registration and listing requirements for each target market.

Global Regulatory Intelligence/Consulting

Staying informed about global regulatory changes is essential for companies operating in multiple markets. Global RQC offers regulatory intelligence and consulting services to ensure that you are aware of evolving regulations and can proactively adjust your strategies.

Regulatory Updates: We provide timely updates on regulatory changes that may affect your products. This includes changes to FDA guidelines, ISO standards, and international regulatory requirements such as MDR (EU) or PMDA (Japan) regulations.
Global Regulatory Strategy: We help you develop a cohesive regulatory strategy that accounts for variations in global regulations. Whether you’re planning to enter multiple markets or need to navigate new regulatory frameworks, our team provides expert advice on how to remain compliant in every jurisdiction.

By offering global regulatory intelligence, we help you mitigate risks and ensure compliance across multiple regions.

Independent Reviews for 510(k) Submissions

Before submitting your 510(k) application to the FDA, it is crucial to ensure that everything is in order. At Global RQC, we offer independent reviews of your 510(k) submission to provide an additional layer of assurance that your application will meet all the necessary criteria for FDA approval.

Pre-submission Review: We conduct a comprehensive pre-submission review to evaluate the strength of your 510(k) submission. This includes checking for completeness, reviewing technical documentation, and ensuring that your risk management files and clinical evaluation reports meet FDA standards.
Compliance Check: Our team ensures that your 510(k) submission complies with the FDA’s de novo classification process or substantial equivalence standards. We help you identify any gaps in your submission and suggest improvements to increase the likelihood of approval.

With an independent review of your 510(k) submission, you can be confident that your application will meet FDA requirements and avoid delays in the approval process.

Combination Product

Combination products—like drug-device or biologic-device hybrids—present unique challenges due to overlapping regulatory frameworks. Manufacturers must meet requirements for both medical devices and pharmaceuticals, making compliance complex. Global RQC ensures a streamlined regulatory approach tailored to the specific needs of combination products.

We begin by determining the Primary Mode of Action (PMOA), which defines the lead regulatory body (FDA’s CDRH, CDER, or CBER). Accurate classification is critical to avoid costly missteps and delays.

Our team provides expertise in regulatory submissions, ensuring that both device and drug components are thoroughly documented. From 510(k) and PMA submissions to Biologics License Applications (BLA), we help you navigate the process with precision.

Post-market compliance is vital for combination products. Global RQC supports the implementation of robust post-market surveillance systems, ensuring that both safety and performance metrics are monitored effectively. We help manufacturers meet FDA requirements for CGMP and QSR standards, as well as provide strategies for handling adverse events and recalls.

Our key services for combination products include:

Risk Management: Identifying and mitigating risks early in the process.
Integrated Documentation: Preparing submissions that address the combined regulatory needs of drug, device, or biologic components.
Lifecycle Management: Supporting compliance through product development, approval, and market surveillance.

At Global RQC, we are committed to helping manufacturers meet the stringent demands of combination product regulations while accelerating time-to-market.

At Global RQC Med Dev Consulting Solutions, we offer a wide range of regulatory affairs services designed to help medical device companies navigate the complex and ever-changing regulatory landscape. We provide expert guidance to ensure compliance with FDA regulations, ISO standards, and other international regulatory bodies, enabling you to bring safe, effective medical devices to market efficiently. Contact Global RQC today to discuss how our medical device regulatory affairs services can support your business and ensure regulatory compliance at every step of your product’s journey.

FREQUENTLY ASKED QUESTIONS

What is a Quality Management System (QMS)?

A QMS is a structured system of processes and procedures aimed at ensuring consistent product quality, regulatory compliance, and continuous improvement in the production and delivery of medical devices.

Why is ISO 13485:2016 important for medical device manufacturers?

ISO 13485:2016 ensures that manufacturers consistently produce safe and effective medical devices. Certification to this standard helps companies demonstrate their commitment to quality and regulatory compliance.

What is the FDA's QSR 820, and how does it affect my business?

QSR 820 outlines the requirements for medical device manufacturers in the U.S. to implement a quality system that ensures product safety and effectiveness. It affects all aspects of manufacturing, including design, testing, and post-market activities.

How do I implement a QMS in my medical device business?

Implementing a QMS involves designing processes, creating documentation, training staff, and ensuring compliance with industry standards. We help businesses tailor their QMS to meet specific needs while ensuring regulatory compliance.

What is a QMS Gap Analysis?

A gap analysis identifies deficiencies between your current QMS and regulatory requirements or best practices. This helps prioritize corrective actions to address areas of non-compliance and reduce risks.

How can I prepare for an FDA QSR 820 audit?

Preparation involves reviewing and updating your QMS to ensure it meets FDA requirements. Our team provides support by conducting audits, training your staff, and ensuring your documentation is audit-ready.

What are the key components of ISO 13485?

ISO 13485 covers the requirements for design, production, and post-market surveillance of medical devices. Key components include risk management, CAPA, documentation control, and continuous improvement.

Can Global RQC help with ISO 13485 certification?

Yes, we offer end-to-end support for ISO 13485 certification, from implementing a compliant QMS to preparing for the certification audit and providing post-certification support.

What is CAPA, and why is it important for QMS?

Corrective and Preventive Actions (CAPA) are critical for identifying, investigating, and resolving issues that could affect product quality or safety. CAPA helps prevent recurring problems and ensures continuous improvement.